Clinical Trials Update: July 27, 2006
Heartburn Hypertriglyceridemia Rheumatoid Arthritis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This research study will evaluate an investigational medication to treat frequent heartburn. Volunteers at least 18 who have had heartburn at least two days per week over the past month may be eligible. Participants will receive a study related medical evaluation and the investigational medication at no cost, and travel reimbursement.
The research site is in Raleigh, N.C.
A child with hypercholesterolemia (high blood fat) may be eligible for this study if he or she is 10-17, has been diagnosed with heterozygous familial hypercholesterolemia or has a family member diagnosed with the disorder, and does not have hypertension due to renal disease.
The research site is in New York City.
This study will evaluate the effectiveness of retreatment with rituximab in people with active rheumatoid arthritis (RA) who are receiving methotrexate (MTX) and who have had an inadequate response to tumor necrosis factor (TNF) inhibitors. Volunteers 18-80 may be included who have been diagnosed with RA for at least six months, are receiving outpatient treatment, and have been using MTX 10-25 mg per week for at least 12 weeks. Patients may not participate who have rheumatic autoimmune disease other than RA, a diagnosis of juvenile idiopathic arthritis (JIA), juvenile rheumatoid arthritis (JRA), or RA before age 16.
The research site is in Virginia Beach, Va.
Copyright 2006 Thomson CenterWatch. All rights reserved.